OMNIS is the high-end titration system from Metrohm. It provides users with the possibility to consolidate their wet chemical analysis on a universal platform. With this comes the flexibility to ...

TitrIC has been developed with a focus on water analysis but can likewise be adapted to suit the needs in food, pharmaceutical and plating analysis. More details and application examples can be found ...

ANN ARBOR, MI (May 9, 2012): Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS™), under development by Hygieia, Inc., demonstrate DIGS' potential to improve ...

Thermo Fisher Scientific has announced a joint initiative with METTLER TOLEDO for a combined Titration/Ion Chromatography (IC) system designed to provide a fast, accurate and integrated solution for ...

ODF designed an automated titration system and LabView software for the determination of dissolved oxygen in seawater that can be used both onshore and at sea. Contact Susan Becker for details and ...

Precise water analysis is essential in ensuring pharmaceutical products’ performance, safety, and adherence to regulations. Karl Fischer (KF) titration is a widely used method for water content ...

Glycemic control outcomes were similar between patients with type 2 diabetes who received insulin titration on the basis of an AI-assisted system vs a physician. Real-time artificial intelligence (AI) ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure The OMNIS titration platform provides a ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

MOUNTAIN VIEW, Calif. & GOTHENBURG, Sweden--(BUSINESS WIRE)--Glooko, the leader in diabetes data management, today announced its Mobile Insulin Dosing System (MIDS) has been cleared by the Food and ...

DIGS' potential to perk up blood glucose control for insulin-using patients with type 2 or type 1 diabetes revealed by clinical study of the (DIGS™), under development by Hygieia, Inc. DIGS' potential ...